Cargando…
On 3 legs shall we stand: Combined innovation for treatment of ischemic cardiomyopathy
Autores principales: | Kawabori, Masashi, Hironaka, Camille E., Chen, Frederick Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390607/ https://www.ncbi.nlm.nih.gov/pubmed/36003753 http://dx.doi.org/10.1016/j.xjon.2021.03.025 |
Ejemplares similares
-
Prophylactic routine posterior pericardiotomy: Should we perform it in every patient?
por: Kaleda, Vasily I., et al.
Publicado: (2022) -
Impact of complete revascularization in coronary artery bypass grafting for ischemic cardiomyopathy
por: Nakae, Masaro, et al.
Publicado: (2023) -
Left ventricular function and survival in ischemic cardiomyopathy: Implications for surgical ventricular restoration
por: Adhyapak, Srilakshmi M., et al.
Publicado: (2021) -
Clinical mesenchymal stem cell therapy in ischemic cardiomyopathy
por: Mazine, Amine, et al.
Publicado: (2021) -
Evidence-based selection of the second and third arterial
conduit
por: Gillmore, Taylor, et al.
Publicado: (2020)